Experimental and Molecular Pathology: 2022, vol: , issue:
1)- Laurie B Joseph, Marion K Gordon, Peihong Zhou, Rita A Hahn, Hamdi Lababidi, Claire R Croutch, Patrick J Sinko, Diane E Heck, Debra L Laskin, Jeffrey D Laskin. Sulfur mustard corneal injury is associated with alterations in the epithelial basement membrane and stromal extracellular matrix.Experimental and molecular pathology. 2022, 128: 104807
2)- June K Dunnick, Arun R Pandiri, Keith R Shockley, Ronald Herbert, Deepak Mav, Dhiral Phadke, Ruchir R Shah, B Alex Merrick. Single nucleotide polymorphism patterns associated with a cancer resistant phenotype.Experimental and molecular pathology. 2022, 128: 104812
3)- Ashley Gray, Tiantian Cui, Erica Hlavin Bell, Joseph McElroy, Ebin Sebastian, Fuhai Li, Marjolein Geurts, Kevin Liu, Pierre Robe, S Jaharul Haque, Arnab Chakravarti. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.Experimental and molecular pathology. 2022, 128: 104813
4)- Sepideh Kadkhoda, Soudeh Ghafouri-Fard, Farshid Noorbakhsh, Sima Ravaei, Farzaneh Darbeheshti, Mahsa M Amoli, Reza Taslimi, Abbas Shakoori. The importance of regulatory pathway mediated by Circ0001955 in colorectal cancer.Experimental and molecular pathology. 2022, 128: 104819
5)- Marija S Stankovic, Silvio R De Luka, Sasa Jankovic, Srdjan Stefanovic, Maja Stojanovic, Jelena Nesovic-Ostojic, Nina Japundzic-Zigon, Alexander M Trbovich. ST2 and the alteration of cobalt, sodium, potassium and calcium concentration in acute inflammation.Experimental and molecular pathology. 2022, 128: 104820
7)- Stephen E Fry, Mitchell Kaye, Dara S Missan, Christian Becker, Matthew Shabilla, Delyn Martinez, Erin Bossert, Jeremy Ellis. Microbial community profiling by next-generation DNA sequencing of adenocarcinoma of the prostate with evidence of ochratoxin A producing fungi.Experimental and molecular pathology. 2022, 128: 104831
8)- Weijie Xue, Bingzi Dong, Yixiu Wang, Yuwei Xie, Pu Li, Zhiqi Gong, Zhaojian Niu. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.Experimental and molecular pathology. 2022, 128: 104832
9)- Annamaria Salvati, Ileana Carnevali, Elena Alexandrova, Sofia Facchi, Susanna Ronchi, Laura Libera, Nora Sahnane, Domenico Memoli, Jessica Lamberti, Sonia Amabile, Stefano Pepe, Roberta Tarallo, Fausto Sessa, Alessandro Weisz, Maria Grazia Tibiletti, Francesca Rizzo. Targeted molecular profiling of epithelial ovarian cancer from Italian BRCA wild-type patients with a BRCA and PARP pathways gene panel.Experimental and molecular pathology. 2022, 128: 104833
10)- Nihal Salah Ibrahim, Manal Mohamed Makhlouf, Gehan Hamed Shahin, Mona Kamal Elghamrawy, Nehad Mohammed Hussein. The impact of MCP1-2518A/G and CCR2-V64I genetic polymorphisms in Egyptian sickle cell disease patients.Experimental and molecular pathology. 2022, 128: 104834
12)- Hava Kuçuk, David Laville, Pierre Dal-Col, Violaine Yvorel, Abdulrazzak Sulaiman, Sophie Bayle-Bleuez, Philippe Cosmo, Jean-Michel Vergnon, Olivier Tiffet, Anne-Laure Desage, Fabien Forest. Value of immunohistochemistry in crushed areas of pulmonary neuroendocrine carcinoma.Experimental and molecular pathology. 2022, 128: 104836
13)- Ke Gao, Zhen Su, Hailin Liu, Yan Liu. Retraction notice to "Anti-proliferation and anti-metastatic effects of sevoflurane on human osteosarcoma U2OS and Saos-2 cells" [Experimental and Molecular Pathology 108 (2019) 121-130].Experimental and molecular pathology. 2022, 127: 104784
16)- Shiying Hang, Xianghong Wang, Hai Li. Retraction notice to " Triptolide inhibits viability and migration while promotes apoptosis in nephroblastoma cells by regulation of miR-193b-3p" [Experimental and Molecular Pathology 108 (2019) 80-88].Experimental and molecular pathology. 2022, 127: 104799
17)- Pengmu Xie, Xiuling Wang, Min Kong, Xiuyu Bai, Tao Jiang. Retraction notice to "TRAF4 promotes endometrial cancer cell growth and migration by activation of PI3K/AKT/Oct4 signaling" [Experimental and Molecular Pathology 108 (2019) 9-16].Experimental and molecular pathology. 2022, 127: 104800
18)- Yuxi Qi, Jinliang Li. Retraction notice to "Triptolide inhibits the growth and migration of colon carcinoma cells by down-regulation of miR-191" [Experimental and Molecular Pathology 107 (2019) 23-31].Experimental and molecular pathology. 2022, 127: 104805
19)- Yuxia Liu, Yan Zhang. Retraction notice to "Lycium barbarum polysaccharides alleviate hydrogen peroxide-induced injury by up-regulation of miR-4295 in human trabecular meshwork cells" [Experimental and Molecular Pathology 106 (2019) 109-115].Experimental and molecular pathology. 2022, 127: 104808
21)- Ji Ma, Yong Ding. Retraction notice to " Geniposide suppresses growth, migration and invasion of MKN45 cells by down-regulation of lncRNA HULC" [Experimental and Molecular Pathology 105/3 (2018) 252-259].Experimental and molecular pathology. 2022, 127: 104810
24)- Ashton N Jorgensen, Chowdhury S Abdullah, Md Shenuarin Bhuiyan, Megan Watt, Paari Dominic, Gopi K Kolluru, Christopher G Kevil, Hyung W Nam. Neurogranin regulates calcium-dependent cardiac hypertrophy.Experimental and molecular pathology. 2022, 127: 104815
26)- Mutukuru Mayuri, Praveen T Krishnamurthy, Thangavel Mahalingam Vijayakumar. NK1 receptor antagonistic effect of 17-trifluoromethyl phenyl trinor prostaglandin F2α on the growth of human breast cancer cell line.Experimental and molecular pathology. 2022, 127: 104817
28)- Guanghui Wang, Zi Zhuang, Jianxiang Cheng, Fan Yang, Dachun Zhu, Zhiyuan Jiang, Wensheng Du, Siyuan Shen, Ju Huang, Lei Hua, Youguo Chen. Overexpression of SHARPIN promotes tumor progression in ovarian cancer.Experimental and molecular pathology. 2022, : 104806